Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAO1 | P09471 | 9/20 | 0.65 |
| ▸ | GNAI3 | P08754 | 8/20 | 0.65 |
| ▸ | GNAI1 | P63096 | 8/20 | 0.65 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.61 |
| ▸ | SOD3 | P08294 | 2/20 | 0.54 |
| ▸ | HRH2 | P25021 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10379383 | 1.00 | GNAO1 (0.65) | GNAO1GNAI3GNAI1CXCR4SOD3 | |
| SCHEMBL7336599 | 1.00 | GNAO1 (0.65) | GNAO1GNAI3GNAI1CXCR4SOD3 | |
| SCHEMBL5394694 | 1.00 | GNAO1 (0.65) | GNAO1GNAI3GNAI1CXCR4SOD3 | |
| SCHEMBL162842 | 1.00 | GNAO1 (0.65) | GNAO1GNAI3GNAI1CXCR4SOD3 | |
| SCHEMBL21581269 | 1.00 | GNAO1 (0.65) | GNAO1GNAI3GNAI1CXCR4SOD3 | |
| SCHEMBL21581281 | 1.00 | GNAO1 (0.65) | GNAO1GNAI3GNAI1CXCR4SOD3 | |
| SCHEMBL21581298 | 1.00 | GNAO1 (0.65) | GNAO1GNAI3GNAI1CXCR4SOD3 | |
| SCHEMBL21581259 | 1.00 | GNAO1 (0.65) | GNAO1GNAI3GNAI1CXCR4SOD3 | |
| SCHEMBL21581257 | 1.00 | GNAO1 (0.65) | GNAO1GNAI3GNAI1CXCR4SOD3 | |
| SCHEMBL8723279 | 1.00 | GNAO1 (0.65) | GNAO1GNAI3GNAI1CXCR4SOD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977455-B2 | Analogues of GLP-1 | IPSEN PHARMA, S.A.S. (FR) | 2011-07-12 | — | — | US | claimed |
| US-20090197802-A1 | Analogues of GLP-1 | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) | 2009-08-06 | — | — | US | claimed |
| EP-2067483-A1 | Analogues of GLP-1 | IPSEN PHARMA (FR) | 2009-06-10 | — | — | EP | claimed |
| US-20080108566-A1 | Analogues of GLP-1 | IPSEN PHARMA S.A.S. (FR) | 2008-05-08 | — | — | US | claimed |
| EP-1594529-A4 | ANALOGUES OF GLP-1 | SOD CONSEILS RECH APPLIC (FR) | 2008-01-16 | — | — | EP | claimed |
| US-7268213-B2 | Analogues of GLP-1 | SOCIETE DE CONSELIS DE RECHERCHES ET D'APPLICATIONS SCIENTITIQUES, S.A.S. (FR) | 2007-09-11 | — | — | US | claimed |
| CN-1935839-A | Analogues of glp-1 | SOD CONSEILS RECH APPLIC (FR) | 2007-03-28 | — | — | CN | claimed |
| US-20060217300-A1 | Analogues of glp-1 | BIOMEASURE, INCORPORATED (US) | 2006-09-28 | — | — | US | claimed |
| CN-1750842-A | Analogues of GLP-1 | SOD CONSEILS RECH APPLIC (FR) | 2006-03-22 | — | — | CN | claimed |
| EP-1594529-A2 | ANALOGUES OF GLP-1 | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2005-11-16 | — | — | EP | claimed |
| WO-2004074315-A2 | ANALOGUES OF GLP-1 | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2004-09-02 | — | — | WO | claimed |
| CN-1495198-A | Analogs of glucagon-like peptide-1 | �о���Ӧ�ÿ�ѧЭ��ɷ�����˾ | 2004-05-12 | — | — | CN | claimed |
| US-20040018981-A1 | Analogues of GLP-1 | BIOMEASURE INC., A MASSACHUSETTS CORPORATION | 2004-01-29 | — | — | US | claimed |
| EP-1359159-A2 | Analogues of GLP-1 | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. (FR) | 2003-11-05 | — | — | EP | claimed |
| CN-1329620-A | Glucagon-like peptide-1 analogs | CONSEILS DE RECH SET D APPLIC (FR) | 2002-01-02 | — | — | CN | claimed |
| EP-1137667-A2 | ANALOGUES OF GLP-1 | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. (FR) | 2001-10-04 | — | — | EP | claimed |
| WO-2000034331-A2 | ANALOGUES OF GLP-1 | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES SAS (FR) | 2000-06-15 | — | — | WO | claimed |
| CN-1069529-A | The high temperature oil phase corrosion inhibitor | CHINA NATIONAL PETRO CHEMICAL (CN) | 1993-03-03 | — | — | CN | claimed |
| CN-122006683-A | Mixed mode chromatographic stationary phase based on cyclic polyamine and preparation method thereof | 江苏汉德科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-4659708-A | Anti-leishmanial lepidine derivatives | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1987-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040018981-A1 | Analogues of GLP-1 | GLP1R, IAPP, GIPR | GNAO1 1038/4885GNAI3 640/4885GNAI1 382/4885 |
| US-20090197802-A1 | Analogues of GLP-1 | GLP1R, IAPP, GIPR | GNAO1 1038/4885GNAI3 640/4885GNAI1 382/4885 |
| US-20060217300-A1 | Analogues of glp-1 | GLP1R, IAPP, GIPR | GNAO1 1010/4885GNAI3 538/4885GNAI1 317/4885 |
| US-20080108566-A1 | Analogues of GLP-1 | GLP1R, IAPP, GIPR | GNAO1 1038/4885GNAI3 640/4885GNAI1 382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.